DTaP-Hib (Wuhan Institute of Biological Products)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameDTaP-Hib (Wuhan Institute of Biological Products)
Drug Alias Namecombined vaccine (Wuhan Institute of Biological Products)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Toxoid vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsTetanusDiphtheriaHaemophilus Infections +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesWuhan Institute Of Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWuhan Institute Of Biological Products Co Ltd
Active IndicationsN/A
Inactive IndicationsTetanusDiphtheriaHaemophilus Infections +[4] 

Other Information

ATC CodeN/A
Related LinksN/A